These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24374121)

  • 21. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.
    Yang XX; Hu ZP; Xu AL; Duan W; Zhu YZ; Huang M; Sheu FS; Zhang Q; Bian JS; Chan E; Li X; Wang JC; Zhou SF
    J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three dimensional multicellular co-cultures and anti-cancer drug assays in rapid prototyped multilevel microfluidic devices.
    Hwang H; Park J; Shin C; Do Y; Cho YK
    Biomed Microdevices; 2013 Aug; 15(4):627-634. PubMed ID: 23232700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An on-chip small intestine-liver model for pharmacokinetic studies.
    Kimura H; Ikeda T; Nakayama H; Sakai Y; Fujii T
    J Lab Autom; 2015 Jun; 20(3):265-73. PubMed ID: 25385717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
    Haaz MC; Rivory L; Riché C; Vernillet L; Robert J
    Cancer Res; 1998 Feb; 58(3):468-72. PubMed ID: 9458091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of irinotecan.
    Kuhn JG
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):39-42. PubMed ID: 9726089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics and tissue distribution of irinotecan hydrochloride nanoparticles].
    Yang FY; Zhang WP; Chen HL; Fu Y; Wang XY; Wei SJ; Yang XY; Zhang YX; Dang HW
    Yao Xue Xue Bao; 2013 Jun; 48(6):940-5. PubMed ID: 23984532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.
    Rivory LP; Riou JF; Haaz MC; Sable S; Vuilhorgne M; Commerçon A; Pond SM; Robert J
    Cancer Res; 1996 Aug; 56(16):3689-94. PubMed ID: 8706009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A polydimethylsiloxane-polycarbonate hybrid microfluidic device capable of generating perpendicular chemical and oxygen gradients for cell culture studies.
    Chang CW; Cheng YJ; Tu M; Chen YH; Peng CC; Liao WH; Tung YC
    Lab Chip; 2014 Oct; 14(19):3762-72. PubMed ID: 25096368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced maintenance and functions of rat hepatocytes induced by combination of on-site oxygenation and coculture with fibroblasts.
    Nishikawa M; Kojima N; Komori K; Yamamoto T; Fujii T; Sakai Y
    J Biotechnol; 2008 Jan; 133(2):253-60. PubMed ID: 17936393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.
    Ji Y; Hayashi K; Amoh Y; Tsuji K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Hoffman RM
    Anticancer Res; 2007; 27(2):713-8. PubMed ID: 17465193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination cancer chemotherapy using a DNA topoisomerase inhibitor CPT-11, as a core agent--the in vitro evaluation].
    Oguro M; Seki Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1556-61. PubMed ID: 1651682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysoxylum binectariferum bark as a new source of anticancer drug camptothecin: bioactivity-guided isolation and LCMS-based quantification.
    Jain SK; Meena S; Gupta AP; Kushwaha M; Uma Shaanker R; Jaglan S; Bharate SB; Vishwakarma RA
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3146-9. PubMed ID: 24878199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microfluidic chip integrated with flexible PDMS-based electrochemical cytosensor for dynamic analysis of drug-induced apoptosis on HeLa cells.
    Cao JT; Zhu YD; Rana RK; Zhu JJ
    Biosens Bioelectron; 2014 Jan; 51():97-102. PubMed ID: 23942358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
    Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
    Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
    Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
    Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
    Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.
    Kaneda N; Nagata H; Furuta T; Yokokura T
    Cancer Res; 1990 Mar; 50(6):1715-20. PubMed ID: 2306725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.